Semax and ADHD: separating Russian nootropic hype from real evidence

What did @sally.swalling actually say?

Sally describes taking semax, which she calls "C-Max," every morning after waking. She says she reconstitutes it with 2ml bacteriostatic water and draws "1 MEG," meaning 1 milligram, into an insulin syringe at the 20-unit mark. Her caption describes feeling "clear, in the moment and calm" as the result. That's the claim stack: a specific peptide, a specific preparation method, a specific dose, and a specific cognitive effect.

To be precise about what she actually said verbally: she describes the reconstitution process and unit measurement. The subjective effects appear in the caption rather than the transcript. Worth keeping those separate, because one is a dosing description and the other is a feelings report, and they carry different evidentiary weight.

Does the science back this up?

Partially, but the human evidence is thin, and the dosing math deserves scrutiny. Semax is a synthetic heptapeptide analogue of ACTH(4-7), originally developed in Russia. It has a plausible mechanism: it appears to upregulate brain-derived neurotrophic factor (BDNF) and modulate dopaminergic and serotonergic systems, which could theoretically support attention and mood regulation.

The problem is that most of the meaningful research was conducted in Russian clinical settings with poor translation into peer-reviewed Western literature. Dolotov et al. (2006, Bioorganic and Medicinal Chemistry) documented BDNF-related effects in rodent models. Akhapkina and Akhapkin (2014, Neuroscience and Behavioral Physiology) reviewed Russian-language clinical data suggesting benefits in cognitive decline and stroke recovery. Neither of those populations is "biohacker waking up in the morning." The subjective report of clarity and calm is plausible given semax's proposed mechanism, but it is anecdotal and uncontrolled. Feeling good after a morning ritual involving a syringe and a routine is also consistent with placebo and behavioral priming effects.

What did they get wrong (or right)?

The dosing math has a real problem. Sally says she uses 2ml bacteriostatic water to reconstitute and draws 20 units on an insulin syringe for "1 MEG" (1mg). Standard U-100 insulin syringes measure 1ml as 100 units. So 20 units equals 0.2ml. If 2ml contains the full vial, the concentration and resulting dose depend entirely on how much semax was in the vial to begin with, which she does not specify. Without knowing the vial's total peptide content, "20 units" tells viewers essentially nothing useful about the actual dose they would be taking. This is not a minor omission. It's the kind of gap that turns a dosing tutorial into a guessing game.

What she got right: she does not claim semax treats or cures ADHD. She uses the hashtag and describes subjective effects, which is a meaningful distinction. She also includes a "not medical advice" disclaimer, which is standard but at least present. The reconstitution with bacteriostatic water is the correct diluent choice for peptide storage stability.

What should you actually know?

Semax is not approved by the FDA or TGA. In Australia, where the tagged brand Alpha Research Australia appears to operate, peptides like semax exist in a regulatory grey zone. They are not approved therapeutic goods for general sale. Sourcing, purity, and sterility are unverified in the consumer market, and subcutaneous or intranasal self-administration carries real infection and dosing risk.

The ADHD angle is worth addressing directly. There are no randomized controlled trials of semax in ADHD populations. Zero. The hashtag is doing marketing work, not scientific work. People with ADHD who are considering stopping or supplementing prescribed medication based on TikTok peptide content are making a decision without clinical evidence to support it.

If you're genuinely interested in peptide research, the honest answer is that some signals in the preclinical literature are interesting. But interesting preclinical signals have a long and humbling history of not translating to safe, effective human treatments.

Our bottom line

Sally's description of her personal routine is honest about being subjective, and she avoids the worst overclaims. But the dosing explanation is incomplete in a way that could genuinely mislead viewers trying to replicate it. The cognitive benefit claims for semax, while mechanistically plausible, remain unproven in healthy adults. Anyone drawn to this content should understand they are looking at an n-of-1 anecdote from a person with a discount code, not a clinical recommendation.